Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05539508
Other study ID # 2021-A01986-35
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date October 1, 2022
Est. completion date July 1, 2027

Study information

Verified date August 2022
Source University Hospital, Grenoble
Contact Carole Peyrin, PhD
Phone 04 76 82 58 79
Email carole.peyrin@univ-grenoble-alpes.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Despite its low spatial resolution, peripheral vision is very useful for rapidly categorizing a visual scene. Low spatial frequencies of a visual stimulus available in peripheral vision would allow a coarse categorization of the scene and objects (deciding, for example, whether it is an urban or natural landscape). This first representation would then trigger predictive mechanisms which would subsequently guide a more detailed visual analysis in central vision. The psychophysical studies that the investigators have already conducted in this scientific context has been carried out under normal vision conditions. The objective of this project is to study the influence of peripheral vision on central vision with an original approach: What are the consequences of a loss of peripheral vision on the processing performed in central vision? The project will concern patients with glaucoma. This ophthalmic pathology particularly affects the peripheral retina and thus represents a good pathological cognitive model of a visual recognition system in which peripheral vision is less important. The investigators will conduct psychophysical studies with glaucomatous patients and healthy volunteers with normal vision. All participants will be required to perform a short experiment on a computer (15 minutes) where they will look at different photographs of scenes of different luminance and spatial frequencies. Participants will have to perform various tasks on these images using the keys on the keyboard.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 120
Est. completion date July 1, 2027
Est. primary completion date July 1, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: For patients : - between 18 and 80 years old - stable bilateral primary open angle glaucoma (POAG) - visual acuity > 5/10 for distant vision for the eye tested - peripheral visual field defect on the eye tested measured through a Humphrey Visual Field Analyzer For healthy volunteers : - between 18 and 80 years old - visual acuity > 5/10 - absence of ophthalmologic disease other than Glaucoma (age-related macular degeneration, cataract except for uncomplicated cataract surgery, amblyopia, optic neuropathy, diabetic retinopathy …) Exclusion Criteria: - ophthalmologic disease other than Glaucoma (age-related macular degeneration, cataract except for uncomplicated cataract surgery, amblyopia, optic neuropathy, diabetic retinopathy …) - treated with medication that might compromise sustained attention (benzodiazepine, narcoleptics)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Psychophysical evaluation
All participants will be required to perform a short experiment on a computer (15 minutes) where they will look at different photographs of scenes of different luminance and spatial frequencies. They will have to perform various tasks on these images using the keys on the keyboard.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Grenoble

References & Publications (3)

Peyrin C, Roux-Sibilon A, Trouilloud A, Khazaz S, Joly M, Pichat C, Boucart M, Krainik A, Kauffmann L. Semantic and Physical Properties of Peripheral Vision Are Used for Scene Categorization in Central Vision. J Cogn Neurosci. 2021 Feb 11:1-15. doi: 10.1162/jocn_a_01689. [Epub ahead of print] — View Citation

Roux-Sibilon A, Rutgé F, Aptel F, Attye A, Guyader N, Boucart M, Chiquet C, Peyrin C. Scene and human face recognition in the central vision of patients with glaucoma. PLoS One. 2018 Feb 26;13(2):e0193465. doi: 10.1371/journal.pone.0193465. eCollection 2018. — View Citation

Roux-Sibilon A, Trouilloud A, Kauffmann L, Guyader N, Mermillod M, Peyrin C. Influence of peripheral vision on object categorization in central vision. J Vis. 2019 Dec 2;19(14):7. doi: 10.1167/19.14.7. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Psychophysical measure : Percentage of correct response Measure calculated by the comparison between the expected response and the response provided by the participant for each trial of the experiment Through study completion of 45 months
Primary Psychophysical measure : Mean reaction time in milliseconds Measure calculated by averaging the time in milliseconds taken by the participant to provide the response for each trial of the experiment Through study completion of 45 months
See also
  Status Clinical Trial Phase
Completed NCT02565173 - Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma Phase 3
Completed NCT06437639 - MEXIDOL® Sequential Therapy of Patients With Primary Open-angle Glaucoma (POAG) Phase 4
Terminated NCT02226094 - Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension Phase 1/Phase 2
Completed NCT03131167 - Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma Phase 1
Completed NCT01917383 - A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma Phase 2
Completed NCT02829996 - Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG Phase 2